Patents by Inventor Marie Selzer

Marie Selzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING MEIBOMIAN GLAND DISEASE
    Publication number: 20120088739
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: December 1, 2011
    Publication date: April 12, 2012
    Applicant: THE UNIVERSITY OF MIAMI
    Inventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
  • METHOD FOR TREATING MEIBOMIAN GLAND DISEASE
    Publication number: 20110039805
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: July 21, 2010
    Publication date: February 17, 2011
    Applicant: The University of Miami
    Inventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
  • Methods and compositions for treating meibomian gland disease
    Publication number: 20080214510
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: October 11, 2007
    Publication date: September 4, 2008
    Inventors: Stephen C. PFLUGFELDER, Balakrishna L. LOKESHWAR, Marie SELZER
  • Methods for treating ocular rosacea
    Publication number: 20060154901
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: December 7, 2005
    Publication date: July 13, 2006
    Inventors: Stephen Pflugfelder, Balakrishna Lokeshwar, Marie Selzer
  • Method for treating meibomian gland disease
    Publication number: 20030114426
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Application
    Filed: August 22, 2002
    Publication date: June 19, 2003
    Inventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
  • Method for treating meibomian gland disease
    Patent number: 6455583
    Abstract: A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: September 24, 2002
    Assignee: The University of Miami
    Inventors: Stephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer